Department of Upper Gastro-Intestinal Surgery, Queen Elizabeth Hospital, Birmingham, UK.
Midlands Abdominal and Retroperitoneal Sarcoma Unit (MARSU), Queen Elizabeth Hospital, Birmingham, UK.
Br J Surg. 2016 Jan;103(1):27-34; discussion 34. doi: 10.1002/bjs.9904. Epub 2015 Sep 2.
The effectiveness of perioperative antibiotics in reducing surgical-site infection (SSI) and overall nosocomial infections in patients undergoing laparoscopic cholecystectomy for biliary colic and low- and moderate-risk cholecystitis (Tokyo classification) is unclear. A systematic review and meta-analysis was performed to assess this.
Searches were conducted of the MEDLINE, Embase and Cochrane databases. Only randomized clinical trials (RCTs) were included. The analysis was performed using the random-effects method, and the risk ratio (RR) with 95 per cent c.i. was employed.
Nineteen RCTs, published between 1997 and 2015, with a total of 5259 participants, of whom 2709 (51·5 per cent) were treated with antibiotics, were included. SSI and overall nosocomial infections were detected in 2·4 and 4·2 per cent respectively of patients given perioperative antibiotics, and in 3·2 and 7·2 per cent of those who received no antibiotics. Antibiotics did not significantly reduce the risk of SSI (RR 0·81, 95 per cent c.i. 0·58 to 1·13; P = 0·21) or overall nosocomial infections (RR 0·64, 0·36 to 1·14; P = 0·13). There was no significant between-study heterogeneity for SSI, but significant between-study heterogeneity in the eight studies that reported nosocomial infections. Analysis of studies considered to be high quality, grouped according to the timing of antibiotics (preoperative only or perioperative) and reporting intention-to-treat analyses, again failed to show a significant reduction in SSI.
Antibiotics should not be administered before laparoscopic cholecystectomy in patients with biliary colic and/or low- and moderate-risk cholecystitis.
对于接受腹腔镜胆囊切除术治疗胆绞痛和低危及中危胆囊炎(东京分类)的患者,围手术期抗生素在降低手术部位感染(SSI)和医院获得性感染总体发生率方面的有效性尚不清楚。本系统评价和荟萃分析旨在对此进行评估。
对 MEDLINE、Embase 和 Cochrane 数据库进行检索。仅纳入随机临床试验(RCT)。采用随机效应法进行分析,采用风险比(RR)及其 95%可信区间(CI)。
共纳入 19 项 RCT,发表于 1997 年至 2015 年期间,共计 5259 名参与者,其中 2709 名(51.5%)接受了抗生素治疗。接受围手术期抗生素治疗的患者中 SSI 和医院获得性感染的发生率分别为 2.4%和 4.2%,未接受抗生素治疗的患者中 SSI 和医院获得性感染的发生率分别为 3.2%和 7.2%。抗生素并未显著降低 SSI 的风险(RR 0.81,95%CI 0.58 至 1.13;P=0.21)或医院获得性感染的风险(RR 0.64,0.36 至 1.14;P=0.13)。SSI 无显著异质性,但 8 项报告医院获得性感染的研究存在显著异质性。根据抗生素使用时机(仅术前或围手术期)和意向治疗分析报告情况对高质量研究进行分组分析,也未能显示 SSI 发生率显著降低。
对于胆绞痛和/或低危及中危胆囊炎患者,不应在腹腔镜胆囊切除术前给予抗生素。